These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14176704)

  • 1. [THROMBOTEST IN ANTICOAGULANT CONTROL: A COMPARATIVE STUDY WITH QUICK'S ONE-STAGE PROTHROMBIN DETERMINATION].
    RETIEF FP
    S Afr Med J; 1964 Jul; 38():534-8. PubMed ID: 14176704
    [No Abstract]   [Full Text] [Related]  

  • 2. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 4. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE LABORATORY CONTROL OF ANTICOAGULANT THERAPY. QUICK'S ONE-STAGE PROTHROMBIN TIME COMPARED WITH THROMBOTEST.
    COUNIHAN TB; FARRELL I; KEELAN P
    Ir J Med Sci; 1964 Jan; 457():31-6. PubMed ID: 14113901
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 9. INITIAL EXPERIENCE WITH THROMBOTEST.
    MILLER AL; FARRER-BROWN G; PETHER J
    J Clin Pathol; 1964 Mar; 17(2):182-4. PubMed ID: 14149946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evaluation of an automated amidolytic factor X assay in monitoring anti-vitamin K treatment.
    van Wijk EM; Kahlé LH; Jeletich A; ten Cate JW
    Scand J Haematol; 1982 Aug; 29(2):105-14. PubMed ID: 6813960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M; Béguin S; Hemker HC
    Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THROMBOPLASTIN FORMATION.
    POOL JG
    Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of neodymium 3-sulfo-isonicotinate on the mechanism of coagulation in guinea pigs and rabbits].
    Tremblay J; Archambault A
    Rev Can Biol; 1967 Mar; 26(1):1-9. PubMed ID: 6053477
    [No Abstract]   [Full Text] [Related]  

  • 15. "THROMBOTEST" AND PROTHROMBIN TIME: A CONTROLLED CLINICAL TRIAL.
    ROZENBERG MC; KRONENBERG H; FIRKIN BG
    Australas Ann Med; 1965 Feb; 14():3-12. PubMed ID: 14271789
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.
    Shanberge JN; Matsuoka T
    Thromb Diath Haemorrh; 1966 May; 15(3):442-50. PubMed ID: 5989030
    [No Abstract]   [Full Text] [Related]  

  • 17. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
    Dickneite G
    Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTICOAGULANT THERAPY--BOON OR BANE?
    CELANDER DR; CELANDER E; MARTIN CG
    J Am Osteopath Assoc; 1964 Dec; 64():359-65. PubMed ID: 14233113
    [No Abstract]   [Full Text] [Related]  

  • 19. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION.
    MOSCHOS CB; WONG PC; SISE HS
    JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
    Pagliano FM; Cestari G; Slucca P
    Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.